Preserflo microshunt shows good outcomes out to 2 years in primary open-angle glaucoma

Two-year results of a multicenter European study showed that the Preserflo microshunt, an ab externo filtration surgery device, safely reduced IOP in eyes with primary open-angle glaucoma.
In 81 patients aged between 18 and 85 years who were not adequately controlled on maximal tolerated medical therapy, mean IOP decreased from 21.7 mm Hg at baseline to 14.5 mm Hg at 1 year and was stable at 2 years. Mean number of medications decreased from 2.1 at baseline to 0.5 at 2 years, with 73.8% of patients requiring no medications. No (Read more...)

Full Story →